BDBM32378 adenosine-derived inhibitor, 12 adenosine-derived inhibitor (Grp78), 13
adenosine-derived inhibitor (Grp78), 14 adenosine-derived inhibitor, 15 BDBM32381
adenosine-derived inhibitor (Grp78), 8 BDBM32373 adenosine-derived inhibitor, 7
adenosine-derived inhibitor, 10 adenosine-derived inhibitor (Grp78), 11 BDBM32376
adenosine-derived inhibitor, 11 BDBM32377 adenosine-derived inhibitor (Grp78), 12
adenosine-derived inhibitor, 4 adenosine-derived inhibitor (Grp78), 2 BDBM32370
adenosine-derived inhibitor, 5 adenosine-derived inhibitor (Grp78), 3 BDBM32371
adenosine-derived inhibitor, 9 adenosine-derived inhibitor (Grp78), 9 BDBM32375
Adenosine analog, 10 BDBM59205
Adenosine analog, 15 BDBM59210
Adenosine analog, 18 BDBM59211
Adenosine analog, 19 BDBM59212
Adenosine analog, 5 BDBM59202
Adenosine analog, 8 BDBM59203
Adenosine analog, 9 BDBM59204
Adenosine analogue BDBM50144453 CHEMBL3142239
BDBM50029130 Adenosine dialdehyde CHEMBL165876
BDBM50366480 ATP ADENOSINE TRIPHOSPHATE
BDBM50368125 ADENOSINE DIPHOSPHATE ADP
BDBM59206 Adenosine analog, 11
BDBM59207 Adenosine analog, 12
BDBM59208 Adenosine analog, 13
BDBM59209 Adenosine analog, 14
CHEMBL3559427 Adenosine analogue BDBM50144452
N-Ethylcarboxamidoadenosine Adenosine, N6-Ethyl-carboxamido [3H]NECA Adenosine-5 -(N-ethylcarboxamide) BDBM21241
Adenosine receptor agonist, 7 BDBM200211
Adenosine receptor agonist, 9 BDBM200213
BDBM200215 Adenosine receptor agonist, 11
BDBM200216 Adenosine receptor agonist, 13
BDBM200217 Adenosine receptor agonist, 14
BDBM32372 adenosine-derived inhibitor, 6
BDBM32379 adenosine-derived inhibitor, 13
BDBM32380 adenosine-derived inhibitor, 14
BDBM32382 adenosine-derived inhibitor, 16
BDBM32383 adenosine-derived inhibitor, 17
BDBM50292504 adenosine 5'-(pentahydrogen tetraphosphate)
adenosine-derived inhibitor, 8 BDBM32374
ADPbetaS BDBM50118230 5'-O-[(R)-HYDROXY(THIOPHOSPHONOOXY)PHOSPHORYL]ADENOSINE adenosine-5'-O-beta-thiodiphosphate CHEMBL335206
Ap3A P(1),P(3)-bis(5'-adenosyl) trihydrogen triphosphate BDBM50184368 P(1),P(3)-bis(5'-adenosyl) triphosphate CHEMBL407938 A(5')p3(5')A Adenosine(3)triphosphate adenosine Diadenosine triphosphate adenosine(5')triphospho(5')adenosine
2-(2''-indolylethyloxy)adenosine CHEMBL374461 BDBM50208812
Adenosine 5'-triphosphate derivative CHEMBL3142844 BDBM50026197
BDBM31995 Adenosine Diphosphate (ADP) ADP CHEMBL14830
BDBM50026193 Adenosine 5'-triphosphate derivative CHEMBL3142845
BDBM85527 S-N6-(2-phenylisopropyl) adenosine
CAS_67358 Adenosine-N1-oxide BDBM82541 NSC_67358
CHEMBL476563 Adenosine 5'-methylenebis(sulfonamide) BDBM50263249
adenosine-derived inhibitor (Grp78), 1 BDBM82124
CHEMBL1163074 CysSA BDBM50339905 5'-O-[N-(L-cysteinyl)sulfamoyl]adenosine 5'-O-(N-(L-CYSTEINYL)-SULFAMOYL)ADENOSINE
CAS_3080-29-3 Beta-L-adenosine BDBM82533
CHEMBL1230617 8-Bromo-Adenosine Mono Phosphate BDBM50222467
CHEMBL1775011 8-phenyl-Adenosine Mono Phosphate BDBM50343897
CHEMBL2047559 BDBM50485292 Cis-Cyclobutyl Adenosine Phosphonyl Disphosphate
CHEMBL605670 5'-O-Nitro Adenosine CHEMBL2205239 BDBM50366634
5'-Methylthio Adenosine 5'-Methylthioado BDBM81786
BDBM50367043 CHEMBL604394 CHEMBL3251358 8-(Thioethyl)Adenosine 5'-Triphosphate
BDBM81788 5'-Chloro Adenosine 5'-ChloroAdo
CHEMBL369928 AR-C67085 Adenosine triphosphate derivative BDBM50118223 CHEMBL336292
CHEMBL489640 BDBM50267577 N6-((+/-)-endo-norborn-2-yl)adenosine
CHEMBL606220 CHEMBL1230617 BDBM50367001 8-Bromo-Adenosine Mono Phosphate
Mycophenolic(adenosine-5'-N-acetamido)phosphonate BDBM50338547 CHEMBL1683749
5'-O-(N-(2-hydroxybenzoyl)sulfamoyl)adenosine 5'-O-[N-(salicyl)sulfamoyl] adenosine ((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl 2-hydroxybenzoylsulfamate 5'-O-[N-(salicyl)sulfamoyl]adenosine BDBM50324670 5'-O-[N-(salicyl)-sulfamoyl]-adenosine CHEMBL371502
N-Ethylcarboxamidoadenosine NECA (2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-N-ethyl-3,4-dihydroxyoxolane-2-carboxamide CHEMBL464859 BDBM21220 Adenosine-5-(N-ethylcarboxamide) Adenosine, N6-Ethyl-carboxamido Adenosine analog, 3
2-(3''-(4''-bromo-indolyl)ethyloxy)adenosine BDBM50208797 CHEMBL434377
5''-O-(Sulfamoyl)Adenosine 5''-O-Sulfamoyladenosine CHEMBL471144 BDBM50454088
ATP(4-) BDBM50192459 adenosine 5'-triphosphate(4-) atp cid_16654697
BDBM50205711 N6-methoxy-2-[(4-methoxyphenyl)ethynyl]adenosine CHEMBL220158
BDBM50205724 CHEMBL267421 N6-methoxy-2-[2-(trimethylsilyl)ethynyl]adenosine
BDBM50205725 N6-methoxy-2-[(3-pyridinyl)ethynyl]-adenosine CHEMBL223328
BDBM50208808 2-(3''-(benzotriazole-1''-yl)ethyloxy)adenosine CHEMBL374737
CHEMBL221363 BDBM50208818 2-(3''-(benzoimidazole-1''-yl)ethyloxy)adenosine
CHEMBL223729 BDBM50208814 2-(3''(7''-bromo-indolyl)ethyloxy)adenosine
CHEMBL374320 N6-methoxy-2-[(4-pentylphenyl)ethynyl]adenosine BDBM50205708
N6-methoxy-2-[(4-methylphenyl)ethynyl]adenosine CHEMBL426537 BDBM50205696
N6-methoxy-2-[(4-pyridinyl)ethynyl]adenosine CHEMBL220899 BDBM50205721
CHEMBL610345 2-(l-hexyn-l-yl)-adenosine-5'-N-methyluronamide (30) BDBM50368358 2-(l-hexyn-l-yl)-adenosine-5'-N-methyluronamide (28)
2-(2''-(1''-(p-toluenesulfonyl)indolyl)ethyloxy)adenosine BDBM50208811 CHEMBL221777
ATP{gamma}S adenosine 5'-O-(3-thiotriphosphate) BDBM36312
BDBM50205723 CHEMBL373578 N6-methoxy-2-{[3-(trifluoromethyl)phenyl]ethynyl}adenosine
BDBM50208803 CHEMBL223002 2-(3''-(5''-methoxy-2''-methylindolyl)ethyloxy)adenosine
BDBM50292323 CHEMBL400567 N6-(1,1,3,3-tetramethylisoindolin-2-yloxyl-5-yl) adenosine
BDBM50295364 (8-Bromoadenosine-5'-yl)(adenosine-5'-yl)disulfide CHEMBL560315
BDBM50338549 CHEMBL1683751 Tiazofurin-5'-yl-(adenosine-5'-N-acetamido)phosphonate
CHEMBL1099129 N6-(2,2,6,6-Tetramethylpiperidin-4-yl)adenosine-5'-Nmethylcarboxamide BDBM50317883
CHEMBL375080 BDBM50208813 2-(3''-(1''-(p-toluenesulfonyl)indolyl)ethyloxy)adenosine
N6-(1,1,3,3-Tetramethylisoindolin-2-yloxyl-5-ylmethyl)adenosine BDBM50317875 CHEMBL1098184
N6-(1,1,3,3-Tetramethylisoindolin-5-yl)adenosine-5'-Nmethylcarboxamide BDBM50317880 CHEMBL1099126
N6-(2,2,6,6-tetramethylpiperidin-1-yloxyl-4-yl) adenosine CHEMBL250316 BDBM50292319
N6-methoxy-2-[2-(1-hydroxycyclohexyl)ethynyl]adenosine BDBM50205707 CHEMBL223326
Vidaza BDBM50424715 Adenosine receptor agonist, 12 U-18496 AZACITIDINE Ladakamycin
- Hagenow, S; Affini, A; Pioli, EY; Hinz, S; Zhao, Y; Porras, G; Namasivayam, V; M?ller, CE; Lin, JS; Bezard, E; Stark, H Adenosine A J Med Chem 64: 8246-8262 (2021)
- Taylor, MD; Moos, WH; Hamilton, HW; Szotek, DS; Patt, WC; Badger, EW; Bristol, JA; Bruns, RF; Heffner, TG; Mertz, TE Ribose-modified adenosine analogues as adenosine receptor agonists. J Med Chem 29: 346-53 (1986)
- Cristalli, G; Eleuteri, A; Vittori, S; Volpini, R; Lohse, MJ; Klotz, KN 2-Alkynyl derivatives of adenosine and adenosine-5'-N-ethyluronamide as selective agonists at A2 adenosine receptors. J Med Chem 35: 2363-8 (1992)
- Duroux, R; Agouridas, L; Renault, N; El Bakali, J; Furman, C; Melnyk, P; Yous, S Antagonists of the adenosine A Eur J Med Chem 144: 151-163 (2018)
- Neenan, JP; Opitz, SM; Cooke, CL; Ussery, MA; Morrill, TC; Eckel, LM Adenosine dialdehyde analogs I: Regioselective synthesis of adenosine monoaldehydes Bioorg Med Chem Lett 6: 1381-1386 (1996)
- Li, Z; Filonova, LK; Bradley, EK; Verner, E Compounds and methods for modulating adenosine A2B receptor and adenosine A2A receptor US Patent US11254686 (2022)
- van der Wenden, EM; von Frijtag Drabbe Künzel, JK; Mathôt, RA; Danhof, M; IJzerman, AP; Soudijn, W Ribose-modified adenosine analogues as potential partial agonists for the adenosine receptor. J Med Chem 38: 4000-6 (1995)
- Jacobson, KA; Kirk, KL; Padgett, WL; Daly, JW Functionalized congeners of adenosine: preparation of analogues with high affinity for A1-adenosine receptors. J Med Chem 28: 1341-6 (1985)
- van Tilburg, EW; von Frijtag Drabbe Künzel, J; de Groote, M; Vollinga, RC; Lorenzen, A; IJzerman, AP N6,5'-Disubstituted adenosine derivatives as partial agonists for the human adenosine A3 receptor. J Med Chem 42: 1393-400 (1999)
- Roelen, H; Veldman, N; Spek, AL; von Frijtag Drabbe Künzel, J; Mathôt, RA; IJzerman, AP N6,C8-distributed adenosine derivatives as partial agonists for adenosine A1 receptors. J Med Chem 39: 1463-71 (1996)
- Petrelli, R; Torquati, I; Kachler, S; Luongo, L; Maione, S; Franchetti, P; Grifantini, M; Novellino, E; Lavecchia, A; Klotz, KN; Cappellacci, L 5'-C-Ethyl-tetrazolyl-N(6)-substituted adenosine and 2-chloro-adenosine derivatives as highly potent dual acting A1 adenosine receptor agonists and A3 adenosine receptor antagonists. J Med Chem 58: 2560-6 (2015)
- Cristalli, G; Franchetti, P; Grifantini, M; Vittori, S; Klotz, KN; Lohse, MJ Adenosine receptor agonists: synthesis and biological evaluation of 1-deaza analogues of adenosine derivatives. J Med Chem 31: 1179-83 (1988)
- Bridges, AJ; Moos, WH; Szotek, DL; Trivedi, BK; Bristol, JA; Heffner, TG; Bruns, RF; Downs, DA N6-(2,2-diphenylethyl)adenosine, a novel adenosine receptor agonist with antipsychotic-like activity. J Med Chem 30: 1709-11 (1987)
- Ha, SB; Melman, N; Jacobson, KA; Nair, V New base-altered adenosine analogues: Synthesis and affinity at adenosine A1 and A2A receptors Bioorg Med Chem Lett 7: 3085-3090 (1997)
- Palle, VP; Elzein, EO; Gothe, SA; Li, Z; Gao, Z; Meyer, S; Blackburn, B; Zablocki, JA Structure-affinity relationships of the affinity of 2-pyrazolyl adenosine analogues for the adenosine A2A receptor. Bioorg Med Chem Lett 12: 2935-9 (2002)
- Vittori, S; Camaioni, E; Di Francesco, E; Volpini, R; Monopoli, A; Dionisotti, S; Ongini, E; Cristalli, G 2-alkenyl and 2-alkyl derivatives of adenosine and adenosine-5'-N-ethyluronamide: different affinity and selectivity of E- and Z-diastereomers at A2A adenosine receptors. J Med Chem 39: 4211-7 (1996)
- Jacobson, KA; Tosh, DK; Salvemini, D A3 adenosine receptor agonists US Patent US10577368 (2020)
- Castro Palomino Laria, J; Camacho Gómez, J; El Maatougui, A Adenosine A3 receptor modulators US Patent US10744125 (2020)
- Jagtap, P Adenosine compounds and their use thereof US Patent US8501708 (2013)
- Kozma, E; Jayasekara, PS; Squarcialupi, L; Paoletta, S; Moro, S; Federico, S; Spalluto, G; Jacobson, KA Fluorescent ligands for adenosine receptors. Bioorg Med Chem Lett 23: 26-36 (2012)
- K?se, M; Gollos, S; Karcz, T; Fiene, A; Heisig, F; Behrenswerth, A; Kie?-Kononowicz, K; Namasivayam, V; M?ller, CE Fluorescent-Labeled Selective Adenosine A J Med Chem 61: 4301-4316 (2018)
- Pham, SM; Chen, J; Ansari, A; Jadhavar, PS; Patil, VS; Khan, F; Ramachandran, SA; Agarwal, AK; Chakravarty, S Heterocyclic compounds as adenosine antagonists US Patent US11028058 (2021)
- Montgomery, JA; Thomas, HJ; Zell, AL; Einsphar, HM; Bugg, CE Study on the inhibition of adenosine deaminase. J Med Chem 28: 1751-3 (1985)
- Bednarska-Szczepaniak, K; Mieczkowski, A; Kierozalska, A; Pavlovi? Safti?, D; G??ba?a, K; Przygodzki, T; Sta?czyk, L; Karolczak, K; Wata?a, C; Rao, H; Gao, ZG; Jacobson, KA; Le?nikowski, ZJ Synthesis and evaluation of adenosine derivatives as A Eur J Med Chem 223: (2021)
- van Tilburg, EW; von Frijtag Drabbe Kunzel, J; de Groote, M; IJzerman, AP 2,5'-Disubstituted adenosine derivatives: evaluation of selectivity and efficacy for the adenosine A(1), A(2A), and A(3) receptor. J Med Chem 45: 420-9 (2002)
- van der Wenden, EM; Carnielli, M; Roelen, HC; Lorenzen, A; von Frijtag Drabbe Künzel, JK; IJzerman, AP 5'-substituted adenosine analogs as new high-affinity partial agonists for the adenosine A1 receptor. J Med Chem 41: 102-8 (1998)
- Peet, NP; Lentz, NL; Meng, EC; Dudley, MW; Ogden, AM; Demeter, DA; Weintraub, HJ; Bey, P A novel synthesis of xanthines: support for a new binding mode for xanthines with respect to adenosine at adenosine receptors. J Med Chem 33: 3127-30 (1991)
- Vittori, S; Lorenzen, A; Stannek, C; Costanzi, S; Volpini, R; IJzerman, AP; Kunzel, JK; Cristalli, G N-cycloalkyl derivatives of adenosine and 1-deazaadenosine as agonists and partial agonists of the A(1) adenosine receptor. J Med Chem 43: 250-60 (2000)
- Baraldi, PG; Cacciari, B; Spalluto, G; Ji, XD; Olah, ME; Stiles, G; Dionisotti, S; Zocchi, C; Ongini, E; Jacobson, KA Novel N6-(substituted-phenylcarbamoyl)adenosine-5'-uronamides as potent agonists for A3 adenosine receptors. J Med Chem 39: 802-6 (1996)
- Siddiqi, SM; Jacobson, KA; Esker, JL; Olah, ME; Ji, XD; Melman, N; Tiwari, KN; Secrist, JA; Schneller, SW; Cristalli, G Search for new purine- and ribose-modified adenosine analogues as selective agonists and antagonists at adenosine receptors. J Med Chem 38: 1174-88 (1995)
- Cappellacci, L; Franchetti, P; Pasqualini, M; Petrelli, R; Vita, P; Lavecchia, A; Novellino, E; Costa, B; Martini, C; Klotz, KN; Grifantini, M Synthesis, biological evaluation, and molecular modeling of ribose-modified adenosine analogues as adenosine receptor agonists. J Med Chem 48: 1550-62 (2005)
- Lohse, MJ; Klotz, KN; Diekmann, E; Friedrich, K; Schwabe, U 2',3'-Dideoxy-N6-cyclohexyladenosine: an adenosine derivative with antagonist properties at adenosine receptors. Eur J Pharmacol 156: 157-60 (1988)
- Volpini, R; Costanzi, S; Lambertucci, C; Vittori, S; Klotz, K; Lorenzen, A; Cristalli, G Introduction of alkynyl chains on C-8 of adenosine led to very selective antagonists of the A(3) adenosine receptor. Bioorg Med Chem Lett 11: 1931-4 (2001)
- Elzein, E; Kalla, R; Li, X; Perry, T; Marquart, T; Micklatcher, M; Li, Y; Wu, Y; Zeng, D; Zablocki, J N6-Cycloalkyl-2-substituted adenosine derivatives as selective, high affinity adenosine A1 receptor agonists. Bioorg Med Chem Lett 17: 161-6 (2006)
- Jacobson, KA; Siddiqi, SM; Olah, ME; Ji, XD; Melman, N; Bellamkonda, K; Meshulam, Y; Stiles, GL; Kim, HO Structure-activity relationships of 9-alkyladenine and ribose-modified adenosine derivatives at rat A3 adenosine receptors. J Med Chem 38: 1720-35 (1995)
- Devine, SM; Gregg, A; Figler, H; McIntosh, K; Urmaliya, V; Linden, J; Pouton, CW; White, PJ; Bottle, SE; Scammells, PJ Synthesis and evaluation of new N6-substituted adenosine-5'-N-methylcarboxamides as A3 adenosine receptor agonists. Bioorg Med Chem 18: 3078-87 (2010)
- Göblyös, A; Brussee, J; Ijzerman, AP; Gao, Z; Jacobson, K A3 adenosine receptor allosteric modulators US Patent US9326978 (2016)
- Schann, S; Mayer, S Adenosine receptor ligands and uses thereof US Patent US9029393 (2015)
- Daly, JW Adenosine receptors: targets for future drugs. J Med Chem 25: 197-207 (1982)
- Yang, X; Michiels, TJM; de Jong, C; Soethoudt, M; Dekker, N; Gordon, E; van der Stelt, M; Heitman, LH; van der Es, D; IJzerman, AP An Affinity-Based Probe for the Human Adenosine A J Med Chem 61: 7892-7901 (2018)
- Zhukov, A; Andrews, SP; Errey, JC; Robertson, N; Tehan, B; Mason, JS; Marshall, FH; Weir, M; Congreve, M Biophysical mapping of the adenosine A2A receptor. J Med Chem 54: 4312-23 (2011)
- Trinh, PNH; Chong, DJW; Leach, K; Hill, SJ; Tyndall, JDA; May, LT; Vernall, AJ; Gregory, KJ Development of Covalent, Clickable Probes for Adenosine A J Med Chem 64: 8161-8178 (2021)
- Jacobson, KA; Thatikonda, SK; Kozma, EE; Spalluto, G; Moro, S; Federico, S Fluorescent antagonists of the A3 adenosine receptor US Patent US9227979 (2016)
- Scammells, P; Baker, S; Bellardinelli, L; Olsson, R; Russell, R; Knevitt, S The design and synthesis of novel adenosine agonists Bioorg Med Chem Lett 6: 811-814 (1996)
- Cristalli, G; Camaioni, E; Vittori, S; Volpini, R; Borea, PA; Conti, A; Dionisotti, S; Ongini, E; Monopoli, A 2-Aralkynyl and 2-heteroalkynyl derivatives of adenosine-5'-N-ethyluronamide as selective A2a adenosine receptor agonists. J Med Chem 38: 1462-72 (1995)
- Elzein, E; Palle, V; Wu, Y; Maa, T; Zeng, D; Zablocki, J 2-Pyrazolyl-N(6)-substituted adenosine derivatives as high affinity and selective adenosine A(3) receptor agonists. J Med Chem 47: 4766-73 (2004)
- Trivedi, BK; Bristol, JA; Bruns, RF; Haleen, SJ; Steffen, RP N6-(arylalkyl)adenosines. Identification of N6-(9-fluorenylmethyl)adenosine as a highly potent agonist for the adenosine A2 receptor. J Med Chem 31: 271-3 (1988)
- Crespo, RA; Dang, Q; Zhou, NE; Guthrie, LM; Snavely, TC; Dong, W; Loesch, KA; Suzuki, T; You, L; Wang, W; O'Malley, T; Parish, T; Olsen, DB; Sacchettini, JC Structure-Guided Drug Design of 6-Substituted Adenosine Analogues as Potent Inhibitors of Mycobacterium tuberculosis Adenosine Kinase. J Med Chem 62: 4483-4499 (2019)
- Pal, S; Choi, WJ; Choe, SA; Heller, CL; Gao, ZG; Chinn, M; Jacobson, KA; Hou, X; Lee, SK; Kim, HO; Jeong, LS Structure-activity relationships of truncated adenosine derivatives as highly potent and selective human A3 adenosine receptor antagonists. Bioorg Med Chem 17: 3733-8 (2009)
- Bridges, AJ; Bruns, RF; Ortwine, DF; Priebe, SR; Szotek, DL; Trivedi, BK N6-[2-(3,5-dimethoxyphenyl)-2-(2-methylphenyl)ethyl]adenosine and its uronamide derivatives. Novel adenosine agonists with both high affinity and high selectivity for the adenosine A2 receptor. J Med Chem 31: 1282-5 (1988)
- Jagtap, PG; Chen, Z; Szabó, C; Klotz, KN 2-(N-acyl) and 2-N-acyl-N(6)-substituted analogues of adenosine and their affinity at the human adenosine receptors. Bioorg Med Chem Lett 14: 1495-8 (2004)
- Wanner, MJ; Von Frijtag Drabbe Künzel, JK; Ijzerman, AP; Koomen, GJ 2-Nitro analogues of adenosine and 1-deazaadenosine: synthesis and binding studies at the adenosine A1, A2A and A3 receptor subtypes. Bioorg Med Chem Lett 10: 2141-4 (2000)
- van Tilburg, EW; van der Klein, PA; von Frijtag Drabbe Künzel, J; de Groote, M; Stannek, C; Lorenzen, A; IJzerman, AP 5'-O-alkyl ethers of N,2-substituted adenosine derivatives: partial agonists for the adenosine A1 and A3 receptors. J Med Chem 44: 2966-75 (2001)
- Tosh, DK; Phan, K; Gao, ZG; Gakh, AA; Xu, F; Deflorian, F; Abagyan, R; Stevens, RC; Jacobson, KA; Katritch, V Optimization of adenosine 5'-carboxamide derivatives as adenosine receptor agonists using structure-based ligand design and fragment screening. J Med Chem 55: 4297-308 (2012)
- Adachi, H; Palaniappan, KK; Ivanov, AA; Bergman, N; Gao, ZG; Jacobson, KA Structure-activity relationships of 2,N(6),5'-substituted adenosine derivatives with potent activity at the A2B adenosine receptor. J Med Chem 50: 1810-27 (2007)
- Baraldi, PG; Fruttarolo, F; Tabrizi, MA; Romagnoli, R; Preti, D; Bovero, A; Pineda de Las Infantas, MJ; Moorman, A; Varani, K; Borea, PA Synthesis and biological evaluation of novel N6-[4-(substituted)sulfonamidophenylcarbamoyl]adenosine-5'-uronamides as A3 adenosine receptor agonists. J Med Chem 47: 5535-40 (2004)
- Sufrin, JR; Spiess, AJ; Kramer, DL; Libby, PR; Miller, JT; Bernacki, RJ; Lee, YH; Borchardt, RT; Porter, CW Targeting 5'-deoxy-5'-(methylthio)adenosine phosphorylase by 5'-haloalkyl analogues of 5'-deoxy-5'-(methylthio)adenosine. J Med Chem 34: 2600-6 (1991)
- Franchetti, P; Messini, L; Cappellacci, L; Grifantini, M; Lucacchini, A; Martini, C; Senatore, G 8-Azaxanthine derivatives as antagonists of adenosine receptors. J Med Chem 37: 2970-5 (1994)
- de Lera Ruiz, M; Lim, YH; Zheng, J Adenosine A2A receptor as a drug discovery target. J Med Chem 57: 3623-50 (2014)
- Abdel-Magid, AF Adenosine Receptor Antagonists as Potential Cancer Therapy. ACS Med Chem Lett 12: 1892-1893 (2021)
- Converso, A; Hartingh, T; Fraley, ME; Garbaccio, RM; Hartman, GD; Huang, SY; Majercak, JM; McCampbell, A; Na, SJ; Ray, WJ; Savage, MJ; Wolffe, C; Yeh, S; Yu, Y; White, R; Zhang, R Adenosine analogue inhibitors of S-adenosylhomocysteine hydrolase. Bioorg Med Chem Lett 24: 2737-40 (2014)
- Jacobson, KA; Tosh, DK Adenosine receptor agonists, partial agonists, and antagonists US Patent US9181253 (2015)
- Hutchinson, SA; Baker, SP; Scammells, PJ Adenosine receptor ligands with oxygenated N6-substituents. Bioorg Med Chem Lett 9: 933-6 (1999)
- Ilas, J; Pecar, S; Hockemeyer, J; Euler, H; Kirfel, A; Müller, CE Development of spin-labeled probes for adenosine receptors. J Med Chem 48: 2108-14 (2005)
- Ceni, C; Catarzi, D; Varano, F; Ben, DD; Marucci, G; Buccioni, M; Volpini, R; Angeli, A; Nocentini, A; Gratteri, P; Supuran, CT; Colotta, V Discovery of first-in-class multi-target adenosine A Eur J Med Chem 201: (2020)
- McGuinness, BF; Ho, KK; Stauffer, TM; Rokosz, LL; Mannava, N; Kultgen, SG; Saionz, K; Klon, A; Chen, W; Desai, H; Rogers, WL; Webb, M; Yin, J; Jiang, Y; Li, T; Yan, H; Jing, K; Zhang, S; Majumdar, KK; Srivastava, V; Saha, S Discovery of novel quinolinone adenosine A2B antagonists. Bioorg Med Chem Lett 20: 7414-20 (2010)
- Härter, M; Kosemund, D; Delbeck, M; Kalthof, B; Wasnaire, P; Süβmeier, F; Lustig, K Heterocyclylmethyl-thienouracile as antagonists of the adenosine-A2B-receptor US Patent US10428083 (2019)
- Lefin, R; van der Walt, MM; Milne, PJ; Terre'Blanche, G Imidazo[1,2-?]pyridines possess adenosine A Bioorg Med Chem Lett 27: 3963-3967 (2017)
- Daly, JW; Hide, I; Bridson, PK Imidazodiazepinediones: a new class of adenosine receptor antagonists. J Med Chem 33: 2818-21 (1990)
- Ji, XD; Melman, N; Jacobson, KA Interactions of flavonoids and other phytochemicals with adenosine receptors. J Med Chem 39: 781-8 (1996)
- Glennon, RA; Tejani-Butt, SM; Padgett, W; Daly, JW Mesoionic xanthine analogues: antagonists of adenosine receptors. J Med Chem 27: 1364-7 (1984)
- Zheng, GZ; Lee, C; Pratt, JK; Perner, RJ; Jiang, MQ; Gomtsyan, A; Matulenko, MA; Mao, Y; Koenig, JR; Kim, KH; Muchmore, S; Yu, H; Kohlhaas, K; Alexander, KM; McGaraughty, S; Chu, KL; Wismer, CT; Mikusa, J; Jarvis, MF; Marsh, K; Kowaluk, EA; Bhagwat, SS; Stewart, AO Pyridopyrimidine analogues as novel adenosine kinase inhibitors. Bioorg Med Chem Lett 11: 2071-4 (2001)
- Iyer, VK; Butler, WB; Horwitz, JP; Rozhin, J; Brooks, SC; Corombos, J; Kessel, D Some adenine and adenosine methylene-bridged estrogens. J Med Chem 26: 162-6 (1983)
- Bing, T; Chang, T; Qi, C; Zhang, N; Liu, X; Shangguan, D Specific interactions between adenosine and streptavidin/avidin. Bioorg Med Chem Lett 22: 7052-5 (2012)
- Durand, IH; Green, RD Cloning of a chick A3 adenosine receptor: characterization of ligand binding and receptor-effector coupling of chick A1 and A3 adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol 363: 81-6 (2001)
- Cappellacci, L; Barboni, G; Palmieri, M; Pasqualini, M; Grifantini, M; Costa, B; Martini, C; Franchetti, P Ribose-modified nucleosides as ligands for adenosine receptors: synthesis, conformational analysis, and biological evaluation of 1'-C-methyl adenosine analogues. J Med Chem 45: 1196-202 (2002)
- Hou, X; Majik, MS; Kim, K; Pyee, Y; Lee, Y; Alexander, V; Chung, HJ; Lee, HW; Chandra, G; Lee, JH; Park, SG; Choi, WJ; Kim, HO; Phan, K; Gao, ZG; Jacobson, KA; Choi, S; Lee, SK; Jeong, LS Structure-activity relationships of truncated C2- or C8-substituted adenosine derivatives as dual acting A2A and A3 adenosine receptor ligands. J Med Chem 55: 342-56 (2012)
- Cristalli, G; Volpini, R; Vittori, S; Camaioni, E; Monopoli, A; Conti, A; Dionisotti, S; Zocchi, C; Ongini, E 2-Alkynyl derivatives of adenosine-5'-N-ethyluronamide: selective A2 adenosine receptor agonists with potent inhibitory activity on platelet aggregation. J Med Chem 37: 1720-6 (1994)
- Suzuki, F; Shimada, J; Shiozaki, S; Ichikawa, S; Ishii, A; Nakamura, J; Nonaka, H; Kobayashi, H; Fuse, E Adenosine A1 antagonists. 3. Structure-activity relationships on amelioration against scopolamine- or N6-((R)-phenylisopropyl)adenosine-induced cognitive disturbance. J Med Chem 36: 2508-18 (1993)
- Bressi, JC; Choe, J; Hough, MT; Buckner, FS; Van Voorhis, WC; Verlinde, CL; Hol, WG; Gelb, MH Adenosine analogues as inhibitors of Trypanosoma brucei phosphoglycerate kinase: elucidation of a novel binding mode for a 2-amino-N(6)-substituted adenosine. J Med Chem 43: 4135-50 (2000)
- Jacobson, KA; Nikodijevic, O; Ji, XD; Berkich, DA; Eveleth, D; Dean, RL; Hiramatsu, K; Kassell, NF; van Galen, PJ; Lee, KS Synthesis and biological activity of N6-(p-sulfophenyl)alkyl and N6-sulfoalkyl derivatives of adenosine: water-soluble and peripherally selective adenosine agonists. J Med Chem 35: 4143-9 (1992)
- Chang, LC; von Frijtag Drabbe Künzel, JK; Mulder-Krieger, T; Westerhout, J; Spangenberg, T; Brussee, J; Ijzerman, AP 2,6,8-trisubstituted 1-deazapurines as adenosine receptor antagonists. J Med Chem 50: 828-34 (2007)
- Robinson, SJ; Petzer, JP; Terre'Blanche, G; Petzer, A; van der Walt, MM; Bergh, JJ; Lourens, AC 2-Aminopyrimidines as dual adenosine A1/A2A antagonists. Eur J Med Chem 104: 177-88 (2015)
- Camacho Gomez, JA; Castro-Palomino Laria, JC 4-aminopyrimidine derivatives and their as as adenosine A2a receptor antagonists US Patent US8796284 (2014)
- de Zwart, M; Kourounakis, A; Kooijman, H; Spek, AL; Link, R; von Frijtag Drabbe Künzel, JK; IJzerman, AP 5'-N-substituted carboxamidoadenosines as agonists for adenosine receptors. J Med Chem 42: 1384-92 (1999)
- González, MP; Moldes del Carmen Terán, M A TOPS-MODE approach to predict adenosine kinase inhibition. Bioorg Med Chem Lett 14: 3077-9 (2004)
- Renk, DR; Skraban, M; Bier, D; Schulze, A; Wabbals, E; Wedekind, F; Neumaier, F; Neumaier, B; Holschbach, M Design, synthesis and biological evaluation of Tozadenant analogues as adenosine A Eur J Med Chem 214: (2021)
- Catarzi, D; Varano, F; Falsini, M; Varani, K; Vincenzi, F; Pasquini, S; Dal Ben, D; Colotta, V Development of novel pyridazinone-based adenosine receptor ligands. Bioorg Med Chem Lett 28: 1484-1489 (2018)
- McGuinness, BF; Cole, AG; Dong, G; Brescia, MR; Shao, Y; Henderson, I; Rokosz, LL; Stauffer, TM; Mannava, N; Kimble, EF; Hicks, C; White, N; Wines, PG; Quadros, E Discovery of 2-aminoimidazopyridine adenosine A(2A) receptor antagonists. Bioorg Med Chem Lett 20: 6845-9 (2010)
- Gregg, A; Bottle, SE; Devine, SM; Figler, H; Linden, J; White, P; Pouton, CW; Urmaliya, V; Scammells, PJ Dual acting antioxidant A1 adenosine receptor agonists. Bioorg Med Chem Lett 17: 5437-41 (2007)
- K?se, M; Schiedel, AC; Bauer, AA; Poschenrieder, H; Burbiel, JC; Akkinepally, RR; Stachel, HD; M?ller, CE Focused screening to identify new adenosine kinase inhibitors. Bioorg Med Chem 24: 5127-5133 (2016)
- Narlawar, R; Lane, JR; Doddareddy, M; Lin, J; Brussee, J; Ijzerman, AP Hybrid ortho/allosteric ligands for the adenosine A(1) receptor. J Med Chem 53: 3028-37 (2010)
- Areias, FM; Brea, J; Gregori-Puigjané, E; Zaki, ME; Carvalho, MA; Domínguez, E; Gutiérrez-de-Terán, H; Proença, MF; Loza, MI; Mestres, J In silico directed chemical probing of the adenosine receptor family. Bioorg Med Chem 18: 3043-52 (2010)
- Salvatore, CA; Jacobson, MA; Taylor, HE; Linden, J; Johnson, RG Molecular cloning and characterization of the human A3 adenosine receptor. Proc Natl Acad Sci U S A 90: 10365-9 (1993)
- Moos, WH; Szotek, DS; Bruns, RF N6-cycloalkyladenosines. Potent, A1-selective adenosine agonists. J Med Chem 28: 1383-4 (1985)
- Beauglehole, AR; Baker, SP; Scammells, PJ New irreversible adenosine A(1) antagonists based on FSCPX. Bioorg Med Chem Lett 12: 3179-82 (2002)
- Vendrell, M; Angulo, E; Casadó, V; Lluis, C; Franco, R; Albericio, F; Royo, M Novel ergopeptides as dual ligands for adenosine and dopamine receptors. J Med Chem 50: 3062-9 (2007)
- Shook, BC; Rassnick, S; Chakravarty, D; Wallace, N; Ault, M; Crooke, J; Barbay, JK; Wang, A; Leonard, K; Powell, MT; Alford, V; Hall, D; Rupert, KC; Heintzelman, GR; Hansen, K; Bullington, JL; Scannevin, RH; Carroll, K; Lampron, L; Westover, L; Russell, R; Branum, S; Wells, K; Damon, S; Youells, S; Beauchamp, D; Li, X; Rhodes, K; Jackson, PF Optimization of arylindenopyrimidines as potent adenosine A(2A)/A(1) antagonists. Bioorg Med Chem Lett 20: 2868-71 (2010)
- Rosse, G Quinazoline Carboxamides as Selective Antagonists of Adenosine 2A Receptor. ACS Med Chem Lett 7: 1014-1015 (2016)
- van der Walt, MM; Terre'Blanche, G Selected C8 two-chain linkers enhance the adenosine A Eur J Med Chem 125: 652-656 (2017)
- Carlsson, J; Yoo, L; Gao, ZG; Irwin, JJ; Shoichet, BK; Jacobson, KA Structure-based discovery of A2A adenosine receptor ligands. J Med Chem 53: 3748-55 (2010)
- van Rhee, AM; Siddiqi, SM; Melman, N; Shi, D; Padgett, WL; Daly, JW; Jacobson, KA Tetrahydrobenzothiophenone derivatives as a novel class of adenosine receptor antagonists. J Med Chem 39: 398-406 (1996)
- Lindell, SD; Moloney, BA; Hewitt, BD; Earnshaw, CG; Dudfield, PJ; Dancer, JE The design and synthesis of inhibitors of adenosine 5'-monophosphate deaminase. Bioorg Med Chem Lett 9: 1985-90 (1999)
- Schwabe, U; Ukena, D; Lohse, MJ Xanthine derivatives as antagonists at A1 and A2 adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol 330: 212-21 (1985)
- Daly, JW; Padgett, WL Agonist activity of 2- and 5'-substituted adenosine analogs and their N6-cycloalkyl derivatives at A1- and A2-adenosine receptors coupled to adenylate cyclase. Biochem Pharmacol 43: 1089-93 (1992)
- Groziak, MP; Huan, ZW; Ding, H; Meng, Z; Stevens, WC; Robinson, PD Effect of a chemical modification on the hydrated adenosine intermediate produced by adenosine deaminase and a model reaction for a potential mechanism of action of 5-aminoimidazole ribonucleotide carboxylase. J Med Chem 40: 3336-45 (1997)
- Beukers, MW; Wanner, MJ; Von Frijtag Drabbe Künzel, JK; Klaasse, EC; IJzerman, AP; Koomen, GJ N6-cyclopentyl-2-(3-phenylaminocarbonyltriazene-1-yl)adenosine (TCPA), a very selective agonist with high affinity for the human adenosine A1 receptor. J Med Chem 46: 1492-503 (2003)
- Beukers, MW; Chang, LC; von Frijtag Drabbe Künzel, JK; Mulder-Krieger, T; Spanjersberg, RF; Brussee, J; IJzerman, AP New, non-adenosine, high-potency agonists for the human adenosine A2B receptor with an improved selectivity profile compared to the reference agonist N-ethylcarboxamidoadenosine. J Med Chem 47: 3707-9 (2004)
- J?rg, M; Shonberg, J; Mak, FS; Miller, ND; Yuriev, E; Scammells, PJ; Capuano, B Novel adenosine A(2A) receptor ligands: a synthetic, functional and computational investigation of selected literature adenosine A(2A) receptor antagonists for extending into extracellular space. Bioorg Med Chem Lett 23: 3427-33 (2013)
- Volpini, R; Costanzi, S; Lambertucci, C; Taffi, S; Vittori, S; Klotz, KN; Cristalli, G N(6)-alkyl-2-alkynyl derivatives of adenosine as potent and selective agonists at the human adenosine A(3) receptor and a starting point for searching A(2B) ligands. J Med Chem 45: 3271-9 (2002)
- Chang, LC; Spanjersberg, RF; von Frijtag Drabbe Künzel, JK; Mulder-Krieger, T; Brussee, J; Ijzerman, AP 2,6-disubstituted and 2,6,8-trisubstituted purines as adenosine receptor antagonists. J Med Chem 49: 2861-7 (2006)
- Dal Ben, D; Buccioni, M; Lambertucci, C; Thomas, A; Klotz, KN; Federico, S; Cacciari, B; Spalluto, G; Volpini, R 8-(2-Furyl)adenine derivatives as A?A adenosine receptor ligands. Eur J Med Chem 70: 525-35 (2013)
- Zhang, Y; Jumppanen, M; Maksimainen, MM; Auno, S; Awol, Z; Ghemtio, L; Venkannagari, H; Lehti?, L; Yli-Kauhaluoma, J; Xhaard, H; Boije Af Genn?s, G Adenosine analogs bearing phosphate isosteres as human MDO1 ligands. Bioorg Med Chem 26: 1588-1597 (2018)
- Douglass, JG; deCamp, JB; Fulcher, EH; Jones, W; Mahanty, S; Morgan, A; Smirnov, D; Boyer, JL; Watson, PS Adenosine analogues as inhibitors of P2Y12 receptor mediated platelet aggregation. Bioorg Med Chem Lett 18: 2167-71 (2008)
- Curtis, MA; Varkhedkar, V; Pragnacharyulu, PV; Abushanab, E Adenosine deaminase inhibitors. Synthesis and biological evaluation of aralkyladenines (ARADS). Bioorg Med Chem Lett 8: 1639-42 (1999)
- Jacobson, KA; van Galen, PJ; Williams, M Adenosine receptors: pharmacology, structure-activity relationships, and therapeutic potential. J Med Chem 35: 407-22 (1992)
- González, MP; Terán, C; Teijeira, M; Besada, P; González-Moa, MJ BCUT descriptors to predicting affinity toward A3 adenosine receptors. Bioorg Med Chem Lett 15: 3491-5 (2005)
- Mahan, LC; McVittie, LD; Smyk-Randall, EM; Nakata, H; Monsma, FJ; Gerfen, CR; Sibley, DR Cloning and expression of an A1 adenosine receptor from rat brain. Mol Pharmacol 40: 1-7 (1991)
- Koul, S; Ramdas, V; Barawkar, DA; Waman, YB; Prasad, N; Madadi, SK; Shejul, YD; Bonagiri, R; Basu, S; Menon, S; Reddy, SB; Chaturvedi, S; Chennamaneni, SR; Bedse, G; Thakare, R; Gundu, J; Chaudhary, S; De, S; Meru, AV; Palle, V; Chugh, A; Mookhtiar, KA Design and synthesis of novel, potent and selective hypoxanthine analogs as adenosine A Bioorg Med Chem 25: 1963-1975 (2017)
- Basu, S; Barawkar, DA; Thorat, S; Shejul, YD; Patel, M; Naykodi, M; Jain, V; Salve, Y; Prasad, V; Chaudhary, S; Ghosh, I; Bhat, G; Quraishi, A; Patil, H; Ansari, S; Menon, S; Unadkat, V; Thakare, R; Seervi, MS; Meru, AV; De, S; Bhamidipati, RK; Rouduri, SR; Palle, VP; Chug, A; Mookhtiar, KA Design, Synthesis of Novel, Potent, Selective, Orally Bioavailable Adenosine A J Med Chem 60: 681-694 (2017)
- Rieger, JM; Brown, ML; Sullivan, GW; Linden, J; Macdonald, TL Design, synthesis, and evaluation of novel A2A adenosine receptor agonists. J Med Chem 44: 531-9 (2001)
- Haikarainen, T; Waaler, J; Ignatev, A; Nkizinkiko, Y; Venkannagari, H; Obaji, E; Krauss, S; Lehti?, L Development and structural analysis of adenosine site binding tankyrase inhibitors. Bioorg Med Chem Lett 26: 328-33 (2016)
- Knight, A; Hemmings, JL; Winfield, I; Leuenberger, M; Frattini, E; Frenguelli, BG; Dowell, SJ; Lochner, M; Ladds, G Discovery of Novel Adenosine Receptor Agonists That Exhibit Subtype Selectivity. J Med Chem 59: 947-64 (2016)
- Zhou, G; Aslanian, R; Gallo, G; Khan, T; Kuang, R; Purakkattle, B; De Ruiz, M; Stamford, A; Ting, P; Wu, H; Wang, H; Xiao, D; Yu, T; Zhang, Y; Mullins, D; Hodgson, R Discovery of aminoquinazoline derivatives as human A(2A) adenosine receptor antagonists. Bioorg Med Chem Lett 26: 1348-54 (2016)
- Jacobson, KA; Shi, D; Gallo-Rodriguez, C; Manning, M; Müller, C; Daly, JW; Neumeyer, JL; Kiriasis, L; Pfleiderer, W Effect of trifluoromethyl and other substituents on activity of xanthines at adenosine receptors. J Med Chem 36: 2639-44 (1993)
- Jacobson, KA; Barone, S; Kammula, U; Stiles, GL Electrophilic derivatives of purines as irreversible inhibitors of A1 adenosine receptors. J Med Chem 32: 1043-51 (1989)
- Nair, V; Fesbender, AJ; Miller, LP; Bruce, JL High selectivity of novel isoguanosine analogues for the adenosine A1 receptor Bioorg Med Chem Lett 1: 481-486 (1991)
- Langmead, CJ; Andrews, SP; Congreve, M; Errey, JC; Hurrell, E; Marshall, FH; Mason, JS; Richardson, CM; Robertson, N; Zhukov, A; Weir, M Identification of novel adenosine A(2A) receptor antagonists by virtual screening. J Med Chem 55: 1904-9 (2012)
- Gillerman, I; Fischer, B Investigations into the origin of the molecular recognition of several adenosine deaminase inhibitors. J Med Chem 54: 107-21 (2011)
- Rosse, G Metabolites of the pyrimidine amine preladenant as adenosine a2a receptor antagonists. ACS Med Chem Lett 4: 5-6 (2013)
- Trivedi, BK; Blankley, CJ; Bristol, JA; Hamilton, HW; Patt, WC; Kramer, WJ; Johnson, SA; Bruns, RF; Cohen, DM; Ryan, MJ N6-substituted adenosine receptor agonists: potential antihypertensive agents. J Med Chem 34: 1043-9 (1991)
- Yaziji, V; Rodríguez, D; Gutiérrez-de-Terán, H; Coelho, A; Caamaño, O; García-Mera, X; Brea, J; Loza, MI; Cadavid, MI; Sotelo, E Pyrimidine derivatives as potent and selective A3 adenosine receptor antagonists. J Med Chem 54: 457-71 (2011)
- Yan, W; Ling, L; Wu, Y; Yang, K; Liu, R; Zhang, J; Zhao, S; Zhong, G; Zhao, S; Jiang, H; Xie, C; Cheng, J Structure-Based Design of Dual-Acting Compounds Targeting Adenosine A J Med Chem 64: 16573-16597 (2021)
- Francis, JE; Cash, WD; Psychoyos, S; Ghai, G; Wenk, P; Friedmann, RC; Atkins, C; Warren, V; Furness, P; Hyun, JL Structure-activity profile of a series of novel triazoloquinazoline adenosine antagonists. J Med Chem 31: 1014-20 (1988)
- Scammells, PJ; Baker, SP; Belardinelli, L; Olsson, RA Substituted 1,3-dipropylxanthines as irreversible antagonists of A1 adenosine receptors. J Med Chem 37: 2704-12 (1994)
- Raghu Prasad, M; Raghuram Rao, A; Shanthan Rao, P; Rajan, KS; Meena, S; Madhavi, K Synthesis and adenosine receptor binding studies of some novel triazolothienopyrimidines. Eur J Med Chem 43: 614-20 (2008)
- Lee, CH; Daanen, JF; Jiang, M; Yu, H; Kohlhaas, KL; Alexander, K; Jarvis, MF; Kowaluk, EL; Bhagwat, SS Synthesis and biological evaluation of clitocine analogues as adenosine kinase inhibitors. Bioorg Med Chem Lett 11: 2419-22 (2001)
- Karellas, P; McNaughton, M; Baker, SP; Scammells, PJ Synthesis of bivalent beta2-adrenergic and adenosine A1 receptor ligands. J Med Chem 51: 6128-37 (2008)
- Ishiyama, H; Ohshita, K; Abe, T; Nakata, H; Kobayashi, J Synthesis of eudistomin D analogues and its effects on adenosine receptors. Bioorg Med Chem 16: 3825-30 (2008)
- Hierrezuelo, J; Manuel López-Romero, J; Rico, R; Brea, J; Isabel Loza, M; Cai, C; Algarra, M Synthesis of theophylline derivatives and study of their activity as antagonists at adenosine receptors. Bioorg Med Chem 18: 2081-8 (2010)
- Van der Walt, MM; Terre'Blanche, G; Petzer, A; Lourens, AC; Petzer, JP The adenosine A(2A) antagonistic properties of selected C8-substituted xanthines. Bioorg Chem 49: 49-58 (2013)
- van Muijlwijk-Koezen, JE; Timmerman, H; Vollinga, RC; Frijtag von Drabbe Künzel, J; de Groote, M; Visser, S; IJzerman, AP Thiazole and thiadiazole analogues as a novel class of adenosine receptor antagonists. J Med Chem 44: 749-62 (2001)
- Vu, CB; Shields, P; Peng, B; Kumaravel, G; Jin, X; Phadke, D; Wang, J; Engber, T; Ayyub, E; Petter, RC Triamino derivatives of triazolotriazine and triazolopyrimidine as adenosine A2a receptor antagonists. Bioorg Med Chem Lett 14: 4835-8 (2004)
- Jacobson, KA; Ukena, D; Padgett, W; Daly, JW; Kirk, KL Xanthine functionalized congeners as potent ligands at A2-adenosine receptors. J Med Chem 30: 211-4 (1987)
- Franchetti, P; Cappellacci, L; Vita, P; Petrelli, R; Lavecchia, A; Kachler, S; Klotz, KN; Marabese, I; Luongo, L; Maione, S; Grifantini, M N6-Cycloalkyl- and N6-bicycloalkyl-C5'(C2')-modified adenosine derivatives as high-affinity and selective agonists at the human A1 adenosine receptor with antinociceptive effects in mice. J Med Chem 52: 2393-406 (2009)
- Homma, H; Watanabe, Y; Abiru, T; Murayama, T; Nomura, Y; Matsuda, A Nucleosides and nucleotides. 112. 2-(1-Hexyn-1-yl)adenosine-5'-uronamides: a new entry of selective A2 adenosine receptor agonists with potent antihypertensive activity. J Med Chem 35: 2881-90 (1992)
- Zablocki, JA; Elzein, EO; Palle, VP; Belardinelli, L 2-(N-pyrazolo)adenosines with application as adenosine A2A receptor agonists US Patent USRE47351 (2019)
- Ferguson, GN; Valant, C; Horne, J; Figler, H; Flynn, BL; Linden, J; Chalmers, DK; Sexton, PM; Christopoulos, A; Scammells, PJ 2-aminothienopyridazines as novel adenosine A1 receptor allosteric modulators and antagonists. J Med Chem 51: 6165-72 (2008)
- van Veldhoven, JP; Chang, LC; von Frijtag Drabbe Künzel, JK; Mulder-Krieger, T; Struensee-Link, R; Beukers, MW; Brussee, J; IJzerman, AP A new generation of adenosine receptor antagonists: from di- to trisubstituted aminopyrimidines. Bioorg Med Chem 16: 2741-52 (2008)
- Thompson, RD; Secunda, S; Daly, JW; Olsson, RA Activity of N6-substituted 2-chloroadenosines at A1 and A2 adenosine receptors. J Med Chem 34: 3388-90 (1992)
- Shimada, J; Koike, N; Nonaka, H; Shiozaki, S; Yanagawa, K; Kanda, T; Kobayashi, H; Ichimura, M; Nakamura, J; Kase, H; Suzuki, F Adenosine A2A antagonists with potent anti-cataleptic activity Bioorg Med Chem Lett 7: 2349-2352 (1997)
- Loog, M; Uri, A; Raidaru, G; Järv, J; Ek, P Adenosine-5'-carboxylic acid peptidyl derivatives as inhibitors of protein kinases. Bioorg Med Chem Lett 9: 1447-52 (1999)
- Daly, JW; Padgett, WL; Shamim, MT Analogues of caffeine and theophylline: effect of structural alterations on affinity at adenosine receptors. J Med Chem 29: 1305-8 (1987)
- Robinson, SJ; Petzer, JP; Rousseau, AL; Terre'Blanche, G; Petzer, A; Lourens, AC Carbamate substituted 2-amino-4,6-diphenylpyrimidines as adenosine receptor antagonists. Bioorg Med Chem Lett 26: 734-8 (2016)
- Leung, E; Kwatra, MM; Hosey, MM; Green, RD Characterization of cardiac A1 adenosine receptors by ligand binding and photoaffinity labeling. J Pharmacol Exp Ther 244: 1150-6 (1988)
- Hill, RJ; Oleynek, JJ; Hoth, CF; Kiron, MA; Weng, W; Wester, RT; Tracey, WR; Knight, DR; Buchholz, RA; Kennedy, SP Cloning, expression and pharmacological characterization of rabbit adenosine A1 and A3 receptors. J Pharmacol Exp Ther 280: 122-8 (1997)
- Hajduk, PJ; Gomtsyan, A; Didomenico, S; Cowart, M; Bayburt, EK; Solomon, L; Severin, J; Smith, R; Walter, K; Holzman, TF; Stewart, A; McGaraughty, S; Jarvis, MF; Kowaluk, EA; Fesik, SW Design of adenosine kinase inhibitors from the NMR-based screening of fragments. J Med Chem 43: 4781-6 (2000)
- Comeo, E; Trinh, P; Nguyen, AT; Nowell, CJ; Kindon, ND; Soave, M; Stoddart, LA; White, JM; Hill, SJ; Kellam, B; Halls, ML; May, LT; Scammells, PJ Development and Application of Subtype-Selective Fluorescent Antagonists for the Study of the Human Adenosine A J Med Chem 64: 6670-6695 (2021)
- Matos, MJ; Vilar, S; Kachler, S; Celeiro, M; Vazquez-Rodriguez, S; Santana, L; Uriarte, E; Hripcsak, G; Borges, F; Klotz, KN Development of novel adenosine receptor ligands based on the 3-amidocoumarin scaffold. Bioorg Chem 61: 1-6 (2015)
- El Maatougui, A; Azuaje, J; Gonz?lez-G?mez, M; Miguez, G; Crespo, A; Carbajales, C; Escalante, L; Garc?a-Mera, X; Guti?rrez-de-Ter?n, H; Sotelo, E Discovery of Potent and Highly Selective A2B Adenosine Receptor Antagonist Chemotypes. J Med Chem 59: 1967-83 (2016)
- Cheeseman, MD; Westwood, IM; Barbeau, O; Rowlands, M; Dobson, S; Jones, AM; Jeganathan, F; Burke, R; Kadi, N; Workman, P; Collins, I; van Montfort, RL; Jones, K Exploiting Protein Conformational Change to Optimize Adenosine-Derived Inhibitors of HSP70. J Med Chem 59: 4625-36 (2016)
- Beauglehole, AR; Baker, SP; Scammells, PJ Fluorosulfonyl-substituted xanthines as selective irreversible antagonists for the A(1)-adenosine receptor. J Med Chem 43: 4973-80 (2001)
- van Muijlwijk-Koezen, JE; Timmerman, H; van der Goot, H; Menge, WM; Frijtag Von Drabbe Künzel, J; de Groote, M; IJzerman, AP Isoquinoline and quinazoline urea analogues as antagonists for the human adenosine A(3) receptor. J Med Chem 43: 2227-38 (2000)
- Schneller, SW; Ibay, AC; Christ, WJ; Bruns, RF Linear and proximal benzo-separated alkylated xanthines as adenosine-receptor antagonists. J Med Chem 32: 2247-54 (1989)
- Jacobson, KA; Ji, X; Li, AH; Melman, N; Siddiqui, MA; Shin, KJ; Marquez, VE; Ravi, RG Methanocarba analogues of purine nucleosides as potent and selective adenosine receptor agonists. J Med Chem 43: 2196-203 (2000)
- Shook, BC; Rassnick, S; Hall, D; Rupert, KC; Heintzelman, GR; Hansen, K; Chakravarty, D; Bullington, JL; Scannevin, RH; Magliaro, B; Westover, L; Carroll, K; Lampron, L; Russell, R; Branum, S; Wells, K; Damon, S; Youells, S; Li, X; Osbourne, M; Demarest, K; Tang, Y; Rhodes, K; Jackson, PF Methylene amine substituted arylindenopyrimidines as potent adenosine A(2A)/A(1) antagonists. Bioorg Med Chem Lett 20: 2864-7 (2010)
- Kim, SK; Gao, ZG; Van Rompaey, P; Gross, AS; Chen, A; Van Calenbergh, S; Jacobson, KA Modeling the adenosine receptors: comparison of the binding domains of A2A agonists and antagonists. J Med Chem 46: 4847-59 (2003)
- Taliani, S; Trincavelli, ML; Cosimelli, B; Laneri, S; Severi, E; Barresi, E; Pugliesi, I; Daniele, S; Giacomelli, C; Greco, G; Novellino, E; Martini, C; Da Settimo, F Modulation of A2B adenosine receptor by 1-Benzyl-3-ketoindole derivatives. Eur J Med Chem 69: 331-7 (2013)
- Dal Ben, D; Buccioni, M; Lambertucci, C; Marucci, G; Thomas, A; Volpini, R; Cristalli, G Molecular modeling study on potent and selective adenosine A(3) receptor agonists. Bioorg Med Chem 18: 7923-30 (2010)
- Thompson, RD; Secunda, S; Daly, JW; Olsson, RA N6,9-disubstituted adenines: potent, selective antagonists at the A1 adenosine receptor. J Med Chem 34: 2877-82 (1991)
- Trivedi, BK; Bridges, AJ; Patt, WC; Priebe, SR; Bruns, RF N6-bicycloalkyladenosines with unusually high potency and selectivity for the adenosine A1 receptor. J Med Chem 32: 8-11 (1989)
- Ashton, TD; Baker, SP; Hutchinson, SA; Scammells, PJ N6-substituted C5'-modified adenosines as A1 adenosine receptor agonists. Bioorg Med Chem 16: 1861-73 (2008)
- González, MP; Besada, P; González Moa, MJ; Teijeira, M; Terán, C New QSAR combined strategy for the design of A1 adenosine receptor agonists. Bioorg Med Chem 16: 1658-75 (2008)
- Korboukh, I; Hull-Ryde, EA; Rittiner, JE; Randhawa, AS; Coleman, J; Fitzpatrick, BJ; Setola, V; Janzen, WP; Frye, SV; Zylka, MJ; Jin, J Orally active adenosine A(1) receptor agonists with antinociceptive effects in mice. J Med Chem 55: 6467-77 (2012)
- Jagtap, P; Szabo, C; Salzman, AL Purine derivatives as adenosine A1 receptor agonists and methods of use thereof US Patent US8609833 (2013)
- Jacobson, KA; Gallo-Rodriguez, C; Melman, N; Fischer, B; Maillard, M; van Bergen, A; van Galen, PJ; Karton, Y Structure-activity relationships of 8-styrylxanthines as A2-selective adenosine antagonists. J Med Chem 36: 1333-42 (1993)
- Cowart, M; Lee, CH; Gfesser, GA; Bayburt, EK; Bhagwat, SS; Stewart, AO; Yu, H; Kohlhaas, KL; McGaraughty, S; Wismer, CT; Mikusa, J; Zhu, C; Alexander, KM; Jarvis, MF; Kowaluk, EA Structure-activity studies of 5-substituted pyridopyrimidines as adenosine kinase inhibitors. Bioorg Med Chem Lett 11: 83-6 (2001)
- Katritch, V; Jaakola, VP; Lane, JR; Lin, J; Ijzerman, AP; Yeager, M; Kufareva, I; Stevens, RC; Abagyan, R Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonists. J Med Chem 53: 1799-809 (2010)
- Louvel, J; Guo, D; Soethoudt, M; Mocking, TA; Lenselink, EB; Mulder-Krieger, T; Heitman, LH; IJzerman, AP Structure-kinetics relationships of Capadenoson derivatives as adenosine A1 receptor agonists. Eur J Med Chem 101: 681-91 (2015)
- Vu, CB; Pan, D; Peng, B; Sha, L; Kumaravel, G; Jin, X; Phadke, D; Engber, T; Huang, C; Reilly, J; Tam, S; Petter, RC Studies on adenosine A2a receptor antagonists: comparison of three core heterocycles. Bioorg Med Chem Lett 14: 4831-4 (2004)
- Shook, BC; Chakravarty, D; Barbay, JK; Wang, A; Leonard, K; Alford, V; Powell, MT; Rassnick, S; Scannevin, RH; Carroll, K; Wallace, N; Crooke, J; Ault, M; Lampron, L; Westover, L; Rhodes, K; Jackson, PF Substituted thieno[2,3-d]pyrimidines as adenosine A2A receptor antagonists. Bioorg Med Chem Lett 23: 2688-91 (2013)
- Karton, Y; Jiang, JL; Ji, XD; Melman, N; Olah, ME; Stiles, GL; Jacobson, KA Synthesis and biological activities of flavonoid derivatives as A3 adenosine receptor antagonists. J Med Chem 39: 2293-301 (1996)
- Gomtsyan, A; Didomenico, S; Lee, CH; Stewart, AO; Bhagwat, SS; Kowaluk, EA; Jarvis, MF Synthesis and biological evaluation of pteridine and pyrazolopyrimidine based adenosine kinase inhibitors. Bioorg Med Chem Lett 14: 4165-8 (2004)
- Zhang, X; Rueter, JK; Chen, Y; Moorjani, M; Lanier, MC; Lin, E; Gross, RS; Tellew, JE; Williams, JP; Lechner, SM; Markison, S; Joswig, T; Malany, S; Santos, M; Castro-Palomino, JC; Crespo, MI; Prat, M; Gual, S; Díaz, JL; Saunders, J; Slee, DH Synthesis of N-pyrimidinyl-2-phenoxyacetamides as adenosine A2A receptor antagonists. Bioorg Med Chem Lett 18: 1778-83 (2008)
- Dowling, JE; Vessels, JT; Haque, S; Chang, HX; van Vloten, K; Kumaravel, G; Engber, T; Jin, X; Phadke, D; Wang, J; Ayyub, E; Petter, RC Synthesis of [1,2,4]triazolo[1,5-a]pyrazines as adenosine A2A receptor antagonists. Bioorg Med Chem Lett 15: 4809-13 (2005)
- Yao, G; Haque, S; Sha, L; Kumaravel, G; Wang, J; Engber, TM; Whalley, ET; Conlon, PR; Chang, H; Kiesman, WF; Petter, RC Synthesis of alkyne derivatives of a novel triazolopyrazine as A(2A) adenosine receptor antagonists. Bioorg Med Chem Lett 15: 511-5 (2005)
- Mogensen, JP; Roberts, SM; Bowler, AN; Thomsen, C; Knutsen, LJ The synthesis of new adenosine A3 selective ligands containing bioisosteric isoxazoles. Bioorg Med Chem Lett 8: 1767-70 (1999)
- Marrone, TJ; Straatsma, TP; Briggs, JM; Wilson, DK; Quiocho, FA; McCammon, JA Theoretical study of inhibition of adenosine deaminase by (8R)-coformycin and (8R)-deoxycoformycin. J Med Chem 39: 277-84 (1996)
- Vu, CB; Kiesman, WF; Conlon, PR; Lin, KC; Tam, M; Petter, RC; Smits, G; Lutterodt, F; Jin, X; Chen, L; Zhang, J Tricyclic imidazoline derivatives as potent and selective adenosine A1 receptor antagonists. J Med Chem 49: 7132-9 (2006)
- Peet, NP; Lentz, NL; Dudley, MW; Ogden, AM; McCarty, DR; Racke, MM Xanthines with C8 chiral substituents as potent and selective adenosine A1 antagonists. J Med Chem 36: 4015-20 (1994)
- Pran Kishore, D; Balakumar, C; Raghuram Rao, A; Roy, PP; Roy, K QSAR of adenosine receptor antagonists: Exploring physicochemical requirements for binding of pyrazolo[4,3-e]-1,2,4-triazolo[1,5-c]pyrimidine derivatives with human adenosine A(3) receptor subtype. Bioorg Med Chem Lett 21: 818-23 (2011)
- Palle, VP; Varkhedkar, V; Ibrahim, P; Ahmed, H; Li, Z; Gao, Z; Ozeck, M; Wu, Y; Zeng, D; Wu, L; Leung, K; Chu, N; Zablocki, JA Affinity and intrinsic efficacy (IE) of 5'-carbamoyl adenosine analogues for the A1 adenosine receptor--efforts towards the discovery of a chronic ventricular rate control agent for the treatment of atrial fibrillation (AF). Bioorg Med Chem Lett 14: 535-9 (2003)
- Ujjinamatada, RK; Phatak, P; Burger, AM; Hosmane, RS Inhibition of adenosine deaminase by analogues of adenosine and inosine, incorporating a common heterocyclic base, 4(7)-amino-6(5)H-imidazo[4,5-d]pyridazin-7(4)one. J Med Chem 51: 694-8 (2008)
- Van der Walt, MM; Terre'Blanche, G 1,3,7-Triethyl-substituted xanthines--possess nanomolar affinity for the adenosine A1 receptor. Bioorg Med Chem 23: 6641-9 (2015)
- Manera, C; Betti, L; Cavallini, T; Giannaccini, G; Martinelli, A; Ortore, G; Saccomanni, G; Trincavelli, L; Tuccinardi, T; Ferrarini, PL 1,8-Naphthyridin-4-one derivatives as new ligands of A2A adenosine receptors. Bioorg Med Chem Lett 15: 4604-10 (2005)
- Linden, J; Patel, A; Earl, CQ; Craig, RH; Daluge, SM 125I-labeled 8-phenylxanthine derivatives: antagonist radioligands for adenosine A1 receptors. J Med Chem 31: 745-51 (1988)
- Chang, LC; Spanjersberg, RF; von Frijtag Drabbe Künzel, JK; Mulder-Krieger, T; van den Hout, G; Beukers, MW; Brussee, J; Ijzerman, AP 2,4,6-trisubstituted pyrimidines as a new class of selective adenosine A1 receptor antagonists. J Med Chem 47: 6529-40 (2004)
- Ueeda, M; Thompson, RD; Arroyo, LH; Olsson, RA 2-Alkoxyadenosines: potent and selective agonists at the coronary artery A2 adenosine receptor. J Med Chem 34: 1334-9 (1991)
- Chordia, MD; Murphree, LJ; Macdonald, TL; Linden, J; Olsson, RA 2-Aminothiazoles: a new class of agonist allosteric enhancers of A(1) adenosine receptors. Bioorg Med Chem Lett 12: 1563-6 (2002)
- Lohse, MJ; Klotz, KN; Schwabe, U; Cristalli, G; Vittori, S; Grifantini, M 2-Chloro-N6-cyclopentyladenosine: a highly selective agonist at A1 adenosine receptors. Naunyn Schmiedebergs Arch Pharmacol 337: 687-9 (1988)
- Ueeda, M; Thompson, RD; Arroyo, LH; Olsson, RA 2-aralkoxyadenosines: potent and selective agonists at the coronary artery A2 adenosine receptor. J Med Chem 34: 1340-4 (1991)
- Shimada, J; Suzuki, F; Nonaka, H; Ishii, A 8-Polycycloalkyl-1,3-dipropylxanthines as potent and selective antagonists for A1-adenosine receptors. J Med Chem 35: 924-30 (1992)
- van Galen, PJ; van Bergen, AH; Gallo-Rodriguez, C; Melman, N; Olah, ME; IJzerman, AP; Stiles, GL; Jacobson, KA A binding site model and structure-activity relationships for the rat A3 adenosine receptor. Mol Pharmacol 45: 1101-11 (1994)
- Chang, LC; von Frijtag Drabbe Künzel, JK; Mulder-Krieger, T; Spanjersberg, RF; Roerink, SF; van den Hout, G; Beukers, MW; Brussee, J; Ijzerman, AP A series of ligands displaying a remarkable agonistic-antagonistic profile at the adenosine A1 receptor. J Med Chem 48: 2045-53 (2005)
- Pragnacharyulu, PV; Lu, PJ; Abushanab, E Adenosine deaminase inhibitors. Synthesis and biological evaluation of chain modified analogs of (+)-EHNA Bioorg Med Chem Lett 6: 2417-2420 (1996)
- Hasrat, JA; Pieters, L; Claeys, M; Vlietinck, A; De Backer, JP; Vauquelin, G Adenosine-1 active ligands: cirsimarin, a flavone glycoside from Microtea debilis. J Nat Prod 60: 638-41 (1997)
- Leeson, PD; James, K; Lennon, IC; Liverton, NJ; Aspley, S; Jackson, RG Adenosine-2′-monophosphate derivatives: Structural requirements as substrates for inositol monophosphatase Bioorg Med Chem Lett 3: 1925-1930 (1993)
- Liu, S; Wnuk, SF; Yuan, C; Robins, MJ; Borchardt, RT Adenosine-5'-carboxaldehyde: a potent inhibitor of S-adenosyl-L-homocysteine hydrolase. J Med Chem 36: 883-7 (1993)
- Wang, M; Zhang, J; Andrei, D; Kuczera, K; Borchardt, RT; Wnuk, SF Are L-adenosine and its derivatives substrates for S-adenosyl-L-homocysteine hydrolase? J Med Chem 48: 3649-53 (2005)
- Peet, NP; Dickerson, GA; Abdallah, AH; Daly, JW; Ukena, D Benzo[1,2-c:5,4-c']dipyrazoles: non-xanthine adenosine antagonists. J Med Chem 31: 2034-9 (1988)
- Hutchison, AJ; Webb, RL; Oei, HH; Ghai, GR; Zimmerman, MB; Williams, M CGS 21680C, an A2 selective adenosine receptor agonist with preferential hypotensive activity. J Pharmacol Exp Ther 251: 47-55 (1989)
- Bruns, RF; Lu, GH; Pugsley, TA Characterization of the A2 adenosine receptor labeled by [3H]NECA in rat striatal membranes. Mol Pharmacol 29: 331-46 (1986)
- Amelia, T; van Veldhoven, JPD; Falsini, M; Liu, R; Heitman, LH; van Westen, GJP; Segala, E; Verdon, G; Cheng, RKY; Cooke, RM; van der Es, D; IJzerman, AP Crystal Structure and Subsequent Ligand Design of a Nonriboside Partial Agonist Bound to the Adenosine A J Med Chem 64: 3827-3842 (2021)
- Kim, YC; Ji, XD; Jacobson, KA Derivatives of the triazoloquinazoline adenosine antagonist (CGS15943) are selective for the human A3 receptor subtype. J Med Chem 39: 4142-8 (1996)
- Ravn, J; Qvortrup, K; Rosenbohm, C; Koch, T Design, synthesis, and biological evaluation of LNA nucleosides as adenosine A3 receptor ligands. Bioorg Med Chem 15: 5440-7 (2007)
- Yang, X; van Veldhoven, JPD; Offringa, J; Kuiper, BJ; Lenselink, EB; Heitman, LH; van der Es, D; IJzerman, AP Development of Covalent Ligands for G Protein-Coupled Receptors: A Case for the Human Adenosine A J Med Chem 62: 3539-3552 (2019)
- Bedford, ST; Benwell, KR; Brooks, T; Chen, I; Comer, M; Dugdale, S; Haymes, T; Jordan, AM; Kennett, GA; Knight, AR; Klenke, B; LeStrat, L; Merrett, A; Misra, A; Lightowler, S; Padfield, A; Poullennec, K; Reece, M; Simmonite, H; Wong, M; Yule, IA Discovery and optimization of potent and selective functional antagonists of the human adenosine A2B receptor. Bioorg Med Chem Lett 19: 5945-9 (2009)
- Firooznia, F; Cheung, AW; Brinkman, J; Grimsby, J; Gubler, ML; Hamid, R; Marcopulos, N; Ramsey, G; Tan, J; Wen, Y; Sarabu, R Discovery of benzothiazole-based adenosine A2B receptor antagonists with improved A2A selectivity. Bioorg Med Chem Lett 21: 1933-6 (2011)
- Jacobson, KA; Kirk, KL; Padgett, WL; Daly, JW Functionalized congeners of 1,3-dialkylxanthines: preparation of analogues with high affinity for adenosine receptors. J Med Chem 28: 1334-40 (1985)
- Mantell, SJ; Stephenson, PT; Monaghan, SM; Maw, GN; Trevethick, MA; Yeadon, M; Keir, RF; Walker, DK; Jones, RM; Selby, MD; Batchelor, DV; Rozze, S; Chavaroche, H; Hobson, TJ; Dodd, PG; Lemaitre, A; Wright, KN; Stuart, EF Inhaled adenosine A(2A) receptor agonists for the treatment of chronic obstructive pulmonary disease. Bioorg Med Chem Lett 18: 1284-7 (2008)
- van Rhee, AM; Jiang, JL; Melman, N; Olah, ME; Stiles, GL; Jacobson, KA Interaction of 1,4-dihydropyridine and pyridine derivatives with adenosine receptors: selectivity for A3 receptors. J Med Chem 39: 2980-9 (1996)
- Baraldi, PG; Preti, D; Borea, PA; Varani, K Medicinal chemistry of A3 adenosine receptor modulators: pharmacological activities and therapeutic implications. J Med Chem 55: 5676-703 (2012)
- Kwatra, MM; Leung, E; Hosey, MM; Green, RD N6-phenyladenosines: pronounced effect of phenyl substituents on affinity for A2 adenosine receptors. J Med Chem 30: 954-6 (1987)
- Cottam, HB; Wasson, DB; Shih, HC; Raychaudhuri, A; Di Pasquale, G; Carson, DA New adenosine kinase inhibitors with oral antiinflammatory activity: synthesis and biological evaluation. J Med Chem 36: 3424-30 (1993)
- Esteve, C; Nueda, A; Díaz, JL; Beleta, J; Cárdenas, A; Lozoya, E; Cadavid, MI; Loza, MI; Ryder, H; Vidal, B New pyrrolopyrimidin-6-yl benzenesulfonamides: potent A2B adenosine receptor antagonists. Bioorg Med Chem Lett 16: 3642-5 (2006)
- Cabri, W; Minetti, P; Piersanti, G; Tarzia, G Oxidated derivatives of triazolylpurines useful as ligands of the adenosine A2A receptor and their use as medicaments US Patent US9133197 (2015)
- Cameron, KO; Kurumbail, RG Recent progress in the identification of adenosine monophosphate-activated protein kinase (AMPK) activators. Bioorg Med Chem Lett 26: 5139-5148 (2016)
- Rodr?guez, D; Chakraborty, S; Warnick, E; Crane, S; Gao, ZG; O'Connor, R; Jacobson, KA; Carlsson, J Structure-Based Screening of Uncharted Chemical Space for Atypical Adenosine Receptor Agonists ACS Chem Biol 11: 2763-2772 (2016)
- Carlsson, J; Tosh, DK; Phan, K; Gao, ZG; Jacobson, KA Structure-activity relationships and molecular modeling of 1,2,4-triazoles as adenosine receptor antagonists. ACS Med Chem Lett 3: 715-720 (2012)
- Kim, HO; Ji, XD; Melman, N; Olah, ME; Stiles, GL; Jacobson, KA Structure-activity relationships of 1,3-dialkylxanthine derivatives at rat A3 adenosine receptors. J Med Chem 37: 3373-82 (1994)
- Katsushima, T; Nieves, L; Wells, JN Structure-activity relationships of 8-cycloalkyl-1,3-dipropylxanthines as antagonists of adenosine receptors. J Med Chem 33: 1906-10 (1990)
- Terasaka, T; Nakanishi, I; Nakamura, K; Eikyu, Y; Kinoshita, T; Nishio, N; Sato, A; Kuno, M; Seki, N; Sakane, K Structure-based de novo design of non-nucleoside adenosine deaminase inhibitors. Bioorg Med Chem Lett 13: 1115-8 (2003)
- Jacobson, KA; Kiriasis, L; Barone, S; Bradbury, BJ; Kammula, U; Campagne, JM; Secunda, S; Daly, JW; Neumeyer, JL; Pfleiderer, W Sulfur-containing 1,3-dialkylxanthine derivatives as selective antagonists at A1-adenosine receptors. J Med Chem 32: 1873-9 (1989)
- Bosch, MP; Campos, F; Niubó, I; Rosell, G; Díaz, JL; Brea, J; Loza, MI; Guerrero, A Synthesis and biological activity of new potential agonists for the human adenosine A2A receptor. J Med Chem 47: 4041-53 (2004)
- Alachouzos, G; Lenselink, EB; Mulder-Krieger, T; de Vries, H; IJzerman, AP; Louvel, J Synthesis and evaluation of N-substituted 2-amino-4,5-diarylpyrimidines as selective adenosine A Eur J Med Chem 125: 586-602 (2017)
- Toti, KS; Moss, SM; Paoletta, S; Gao, ZG; Jacobson, KA; Van Calenbergh, S Synthesis and evaluation of N6-substituted apioadenosines as potential adenosine A3 receptor modulators. Bioorg Med Chem 22: 4257-68 (2014)
- Hausler, NE; Devine, SM; McRobb, FM; Warfe, L; Pouton, CW; Haynes, JM; Bottle, SE; White, PJ; Scammells, PJ Synthesis and pharmacological evaluation of dual acting antioxidant A(2A) adenosine receptor agonists. J Med Chem 55: 3521-34 (2012)
- Ishiyama, H; Nakajima, H; Nakata, H; Kobayashi, J Synthesis of hybrid analogues of caffeine and eudistomin D and its affinity for adenosine receptors. Bioorg Med Chem 17: 4280-4 (2009)
- Ohshita, K; Ishiyama, H; Oyanagi, K; Nakata, H; Kobayashi, J Synthesis of hybrid molecules of caffeine and eudistomin D and its effects on adenosine receptors. Bioorg Med Chem 15: 3235-40 (2007)
- Hamilton, HW; Ortwine, DF; Worth, DF; Badger, EW; Bristol, JA; Bruns, RF; Haleen, SJ; Steffen, RP Synthesis of xanthines as adenosine antagonists, a practical quantitative structure-activity relationship application. J Med Chem 28: 1071-9 (1985)
- Van der Walt, MM; Terre'Blanche, G; Petzer, A; Petzer, JP The adenosine receptor affinities and monoamine oxidase B inhibitory properties of sulfanylphthalimide analogues. Bioorg Chem 59: 117-23 (2015)
- Webb, TR; Melman, N; Lvovskiy, D; Ji, XD; Jacobson, KA The utilization of a unified pharmacophore query in the discovery of new antagonists of the adenosine receptor family. Bioorg Med Chem Lett 10: 31-4 (2000)